Incubation period of the coronavirus disease 2019 (COVID-19) in Busan, South Korea.
Coronavirus
Incubation period
Korea
Log-normal distribution
Outbreak
Journal
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
ISSN: 1437-7780
Titre abrégé: J Infect Chemother
Pays: Netherlands
ID NLM: 9608375
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
received:
27
05
2020
revised:
16
06
2020
accepted:
19
06
2020
pubmed:
8
7
2020
medline:
18
8
2020
entrez:
8
7
2020
Statut:
ppublish
Résumé
The assessment of the incubation period, which is the period between the infection and the illness onset, is essential to identify the sufficient isolation period for infectious diseases. In South Korea, a few cases of the coronavirus disease 2019 (COVID-19) were identified after the 14-day self-quarantine program, and the length of this quarantine has raised controversial issues for the Korean public health professionals. We estimated the COVID-19 incubation period using the log-normal distribution from publicly available data. The data were obtained from the press release of the Busan city department of public health and news reports. We collected and analysed information for 47 patients with a median age of 30. We estimated that the median incubation period was three days (95% Confidence Interval, 0.6-8.2). We also did not find any significant difference in the incubation period between males and females. Our findings indicate that a 14-day self-quarantine program should be sufficient to prevent spreading in the infection of suspected individuals with COVID-19 in the community.
Identifiants
pubmed: 32631735
pii: S1341-321X(20)30209-9
doi: 10.1016/j.jiac.2020.06.018
pmc: PMC7311919
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1011-1013Informations de copyright
Copyright © 2020 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest We declare no competing interests.
Références
Euro Surveill. 2020 Feb;25(5):
pubmed: 32046819
Int J Environ Res Public Health. 2020 Apr 29;17(9):
pubmed: 32365703
Lancet Glob Health. 2020 Apr;8(4):e488-e496
pubmed: 32119825
Epidemiol Health. 2020;42:e2020006
pubmed: 32023775
J Clin Med. 2020 Feb 17;9(2):
pubmed: 32079150
Emerg Infect Dis. 2020 Oct;26(10):2406-2410
pubmed: 32487283
Epidemiol Health. 2020;42:e2020007
pubmed: 32035431
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Lancet Infect Dis. 2009 May;9(5):291-300
pubmed: 19393959
J Prev Med Public Health. 2020 May;53(3):164-167
pubmed: 32498138